All posts tagged "Emcure Pharma"
-
51STOCK MARKETBansal Wire Lists At 39% Premium, Emcure Pharma Gains 31% At Debut
Both Bansal Wire and Emcure Pharmaceuticals IPO closed for public subscription on July 5. New Delhi: Two of the most anticipated IPOs...
-
65STOCK MARKETStocks To Watch: Mahindra & Mahindra, Reliance, Wipro, RVNL, Emcure Pharma, Tata Elxsi, ONGC, Vodafone, Others
Key stocks to watch on July 10 include Vodafone Idea, Vedanta, Voltas, Bajaj Healthcare, and more Stocks to Watch Today: Even as the...
-
83STOCK MARKETEmcure Pharma IPO Allotment Today: How To Check Status, Know GMP
Emcure Pharma IPO Allotment Today: Unlisted shares of Emcure Pharma Ltd are trading Rs 390 higher in the grey market, signalling a...
-
102STOCK MARKETEmcure Pharmaceuticals IPO last bidding date today. Should you subscribe? Check GMP, subscription status, key dates
Emcure Pharmaceuticals IPO subscription status: The initial public offering (IPO) of Emcure Pharmaceuticals on the second day of bidding today was positively...
-
59STOCK MARKETEmcure Pharma IPO Day 2: Check Subscription Status, GMP Today
Unlisted shares of Emcure Pharma Ltd are trading Rs 330 higher in the grey market, signalling a 32.74 per cent listing gain...
-
92STOCK MARKET
IPO Update: Emcure Pharmaceuticals IPO Fully Subscribed by 1.32 Times on Day 1
The initial public offering (IPO) of Bain Capital-backed Emcure Pharmaceuticals Ltd got fully subscribed by 1.32 times on the first day of...
-
94STOCK MARKET
Emcure Pharma IPO Opens Today: Should You Subscribe? Check Price, GMP, Lot Size, Recommendations
Analysts have given ‘subscribe’ recommendation with a long-term horizon to the Emcure Pharma IPO Emcure Pharma IPO: The initial public offering of Emcure...
-
63STOCK MARKETUpcoming IPOs: Ola Electric, Emcure Pharma among 12 companies to hit D-street in next 2 months
India’s stock market is gearing up for a flurry of initial public offerings (IPOs) over the next two months, with over two...
-
738STOCK MARKET
Emcure Pharma files DRHP for IPO
Mumbai: Pune-based Emcure Pharmaceuticals, one of India’s biggest unlisted pharma companies, filed its draft red herring prospectus (DRHP) with the market regulator Sebi on Thursday...
